Best Genomics Companies in Spain
The 119 best Genomics companies in Spain in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Splice Bio.
Spain's genomics sector earns its own ranking here: 119 companies tracked, $274M in total disclosed funding, and a funding distribution that tells you exactly where the conviction sits. Splice Bio leads the directory at $57M raised, well ahead of Sequentia Biotech at $11M and Biohope at $9M. No unicorns yet, but the pipeline is real. The global market was valued at roughly $24.3B in 2021 and is forecast to reach $85.1B by 2030 at a 16.37% CAGR, driven by falling sequencing costs and accelerating demand for personalized medicine. Spain's ecosystem is catching that tailwind, with Europa, EIC Fund, and Caixa Capital Risc among the most active backers keeping capital moving through the stack.
What's shaping the next bets? Hot themes right now are hereditary disease genomics, pharmacogenomics, and machine learning drug discovery, and as shown in 2011 research on next-generation sequencing applications, the foundational science has been pointing this direction for a while. I'd also flag that Mukesh Ambani's AGM call naming genomics alongside AI as a sector defining the next decade signals just how far the conversation has moved from niche to mainstream. And Dr Lal Pathlabs eyeing genomics M&A shows diagnostics incumbents treating it as a strategic imperative, not a side bet. So if you're mapping Spain's genomics players by funding momentum, this directory is where to start.
- Genomics Market Surges with PCR and AI Technologies Projected to Reach
Our analysis of 50 Genomics companies
$7.8b in tracked funding; 84% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Genomics companies in Spain
| # | Company | Disclosed funding | Last round | Stage | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Splice Bio Provider of a proprietary platform for gene therapy 37Funding top 29%Growth top 45%Moat top 48%Tech bottom 49% All 7 signals ▾Fundingtop 29% Growthtop 45% Moattop 48% Techbottom 49% Talentbottom 49% Globalbottom 38% Marketbottom 33% Funding: Raised $56.7M across 2 rounds · 2 rounds over 6 yrs (0.3/yr) Growth: Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 37/100 | $57M | 12 mo ago | Series B | 24 | Miquel Vila-Perello CEO | WordPressMySQLPHP+22 | — | — |
| 2 | STAT Diagnostica Provider of a diagnostic platform for molecular diagnostics and immunoassays | $54M | 116 mo ago | Series C | — | Jordi Carrera Co-Founder & Managing Director | — | 113 patents Microfluidic cartridges for nucleic acid purification and on‑chip biochemical assay processing | — |
| 3 | Veritas Intercontinental Provider of genomic services | $23M | 68 mo ago | Acquired | 43 | George Church Founder | WordPress Block EditorWordPressMySQL+33 | — | — |
| 4 | ADmit Therapeutics Provider of diagnostic services for early detection of Alzheimer's disease | $13M | 32 mo ago | Series A | 10 | Jordi Gascon Co-Founder | — | 18 patents Diagnostic biomarkers for Lewy body dementia and Alzheimer’s disease risk assessment | — |
| 5 | Aelix Therapeutics Developer of therapies for treating HIV | $13M | 77 mo ago | Series A | 10 | Christian Brander Co-Founder | — | 25 patents TLR7 agonist adjuvant formulations enhancing HIV vaccine immunogenicity | — |
| 6 | Sequentia biotech Bioinformatics technologies and sevices | $11M | 20 mo ago | Series A | 23 | — | WordPressPleskMySQL+24 | — | — |
| 7 | nLife Therapeutics Oligonucleotide-based therapies for Parkinsons's disease and other CNS disorders | $9M | 144 mo ago | Deadpooled | 17 | — | — | 46 patents Targeted delivery of oligonucleotides/mRNA to specific neurons and hepatic cells | — |
| 8 | Biohope Assay solutions for management of kidney transplant patients | $9M | 1 mo ago | Seed | 31 | Isabel Portero Founder & CEO | WordPressMySQLPHP+18 | — | — |
| 9 | ARTHEx Developer of oligonucleotide therapies for neuromuscular diseases | $8M | 9 mo ago | Series B | 15 | — | WebflowReactstyled-components+11 | — | — |
| 10 | NIMGenetics Diagnostic solutions based on microarray and next-generation sequencing technologies | $8M | 109 mo ago | Acquired | 97 | — | Cart FunctionalityWordPressMySQL+31 | — | — |
| 11 | AB-Biotics Developer of probiotic drugs for dental disorders | $7M | 97 mo ago | Acquired | 34 | Miquel Bonachera Co-Founder & CEO | WordPressPleskMySQL+24 | 145 patents Therapeutic probiotic formulations targeting gut, vaginal, oral, and respiratory health | — |
| 12 | Amadix Provider of diagnostic tools to support personalized cancer treatment | $7M | 16 mo ago | Series A | 35 | Rocio Arroyo CEO | WordPress Block EditorElementorWordPress+25 | — | — |
| 13 | Integra Therapeutics Developer of next generation of gene editing tools to cure diseases | $7M | 9 mo ago | Seed | 9 | Marc Guell Co-Founder | WordPressMySQLPHP+18 | 10 patents Transposase-mediated gene delivery systems for enhanced transgene expression and nuclear localization | — |
| 14 | Europa America Laboratorios Provider of clinical and genetic analysis services | $5M | 91 mo ago | Deadpooled | — | Fidel Lopez Cuesta Co-Founder & CEO | — | — | — |
| 15 | Kimitec Developer of biotechnology and engineered products as alternatives to conventional synthetic chemicals in… | $5M | 43 mo ago | Seed | 275 | — | WordPressPleskApple iCloud Mail+34 | — | 1 launch |
| 16 | Protein Alternatives Developer of diagnostic assays and therapeutics for the treatment of cancer | $5M | 86 mo ago | Funding Raised | — | Martín Pou Romay CEO & MD | — | — | — |
| 17 | Ikan Biotech Provider of preclinical in vivo drug screening assays using Zebra Fish models | $5M | 105 mo ago | Deadpooled | 12 | Roberto Diez Co-Founder & CEO | — | — | — |
| 18 | VIVEbiotech Developer and manufacturer of lentiviral vectors | $4M | 18 mo ago | Seed | 83 | Gurutz Linazasoro Founder & CEO | WordPressMySQLPHP+16 | — | — |
| 19 | Histocell Provider of products and services in cell therapy for regenerative medicine | $3M | 72 mo ago | Series A | 24 | — | Cart FunctionalityWordPressMySQL+19 | 110 patents Regenerative biomaterial scaffolds and antioxidant hydrogel dressings for oral and skin wound healing | — |
| 20 | AptaTargets Provider of therapeutic solutions for ischemic diseases | $3M | 94 mo ago | Series A | 10 | Victor Manuel Gonzalez Muñoz Cofounder and Scientific Advisor | — | — | — |
| 21 | Made of Genes Genomics platform for acquiring, storing, and sharing personal genomic information | $3M | 27 mo ago | Seed | 20 | — | WordPressMySQLPHP+25 | — | — |
| 22 | Flomics Provider of liquid biopsy-based diagnostics services | $2M | 27 mo ago | Seed | 19 | Joao Curado CEO | WordPressPleskMySQL+19 | — | — |
| 23 | Transbiomed Provider of genomics and proteomics based molecular diagnostics solutions | $2M | 184 mo ago | Deadpooled | — | Andreas Doll Co-Founder | — | — | — |
| 24 | MicroViable Therapeutics Developer of next-generation biotherapeutic products for various diseases | $2M | 50 mo ago | Seed | 7 | — | WordPressMySQLPHP+24 | — | 1 partnership |
| 25 | ADNTRO Provider of saliva-based DNA testing kits for genetic studies | $1M | 20 mo ago | Seed | — | Guillermo Pérez-Solero Monzon CEO & Founder | WordPressMySQLRedis+39 | — | — |
| 26 | Genomcore Provider of a platform for personal genomic analysis | $985K | 18 mo ago | Series A | — | Miquel Angel Bru Co-Founder | WordPressApple iCloud MailGoogle Workspace+22 | 4 patents Secure data access control for wireless communication networks | — |
| 27 | GoodGut Diagnosis and treatment of digestive diseases based on intestinal microbiota analysis | $900K | 124 mo ago | Acquired | 12 | Xavier Aldeguer Co Founder | WordPressPleskMySQL+26 | — | 2 awards |
| 28 | Immunostep Diagnostics and clinical research reagents by flow cytometry | $800K | 154 mo ago | Late Stage | 14 | Ricardo Jara Acevedo CEO | Cart FunctionalityWooCommerceWordPress+30 | 12 patents High-throughput assays for extracellular vesicle quantification and one-step phagocytosis/activation/death detection | — |
| 29 | NeoCodex Provider of designs and implements genetic markers/biomarkers for various diseases | $785K | 242 mo ago | Deadpooled | — | Enrique Vazquez Tatay Co-Founder | — | 14 patents Patents concentrated in computing, sensing & instrumentation | — |
| 30 | Era7 Bioinformatics Provider of services in Next Generation Sequencing (NGS) and Bioinformatics services | $631K | 101 mo ago | Series A | — | — | — | — | — |
| 31 | Innoprot Provider of products and services in drug discovery | $628K | 74 mo ago | Funding Raised | 14 | Jorge Gamiz Founder & CEO | Cart FunctionalityWooCommerceWordPress+25 | — | — |
| 32 | Agrasys Online retailer of tools and equipment for garden and field | $579K | 137 mo ago | Seed | 8 | Cristobal Martinez Co-Founder | — | — | — |
| 33 | Biotechvana Software solutions and services for bio-informatics | $451K | 123 mo ago | Funding Raised | — | Carlos Llorens CEO | TypeScriptPHPApexCharts.js+12 | — | — |
| 34 | ASCIRES Provider of precision diagnosis and personalized treatment | $421K | 123 mo ago | Funding Raised | 253 | — | WordPress Block EditorWordPressMySQL+22 | — | 1 award |
| 35 | DNActive Provider of consumer genomic solutions and personalized treatments | $416K | 87 mo ago | Deadpooled | 2 | Juan Antonio Martínez Fiestas CEO | — | — | — |
| 36 | Sistemas Genomicos Inicio - Sistemas Genómicos | $329K | 123 mo ago | Funding Raised | 100 | — | WordPressPleskMySQL+16 | — | — |
| 37 | Pangaea Biotech Provider of drug development and molecular diagnostics services on cancer treatment | $298K | 101 mo ago | Public | 55 | — | WordPressMySQLPHP+22 | 104 patents Molecular diagnostics and targeted oncology therapeutics using nucleic acid isolation and luminescent assays | 1 award |
| 38 | Qgenomics Provider of genomic research and diagnostics services for research purposes | $297K | 59 mo ago | Funding Raised | — | Lluis Armengol CEO and Scientific Director | WordPressAwesompleteMySQL+18 | — | — |
| 39 | Paperdrop Diagnostics Provider of rapid diagnostics tests for ageing issue based on lateral flow immunoassays | $210K | 67 mo ago | Funding Raised | — | Angel Alonso Co-Founder & CFO | — | 4 patents Multiplexed nucleic acid detection and nanoparticle-enhanced lateral flow diagnostic assays | — |
| 40 | Xenopat Developing xenograft models of cancer for drug development and personalized treatment selection | $158K | 65 mo ago | Funding Raised | 4 | Alberto Villanueva Co-Founder | — | — | — |
| 41 | EntreChem Developer of natural origin small molecule drugs for cancer | $150K | 137 mo ago | Funding Raised | — | Francisco Moris Co-Founder & Managing Director | — | — | — |
| 42 | Imegen Provider of genetic tests for the detection of various disease conditions | $140K | 108 mo ago | Acquired | 65 | Manuel Alonso Founder | — | — | — |
| 43 | HAWK Biosystems Developer of clinical assays for quantifying novel biomarkers | $123K | 48 mo ago | Seed | 14 | Fernando Aguirre CEO | WordPressMySQLPHP+28 | — | — |
| 44 | Moirai Biodesign Developer of RNA-based therapeutics and diagnostics for cancer | $115K | 84 mo ago | Seed | 6 | Ivan Dotu Co-founder and CTO | — | — | — |
Top 12 Genomics companies in Spain
#1
Seed · Tres Cantos, Community of Madrid · founded 2015 · 31 employees$8.5Mraised▾
Biohope develops assay solutions for the management of organ rejection in kidney transplant patients. Its flagship product is a 3D-cell culture that enables physicians to tailor immunosuppressants for renal transplant patients. This assay can be used to prescribe a treatment regimen that prevents organ rejection, and adverse immune reactions due to overuse of immunosuppressants.
- May 2026Seed—
- Jun 2019Grant (prize money)$4.4M
- Jan 2017Grant (prize money)$4M
- Jun 2016Grant (prize money)—
#2
Series B · Barcelona, Catalonia · founded 2020 · 24 employees$56.7Mraised▾
Provider of a proprietary platform for gene therapy. The company offers proprietary intein platform technology for treating patients suffering from rare genetic diseases. The company's lead program is in Stargardt disease, the most common inherited retinal disorder caused by mutations in a single gene ABCA4.
- Jun 2025Series B$135M
- Feb 2022Series A$56.7M
- Sep 2020Seed—
#3
Series B · Valencia, Valencian Community · founded 2018 · 15 employees$8Mraised▾
Developer of oligonucleotide therapies for neuromuscular diseases. The company offers products that are involved in neuromuscular diseases, focusing on Myotonic Dystrophy. The company's lead candidate inhibits miRNAs from repressing MBNL1/2, to compensate for MBNL loss of function.
- Sep 2025Series B$40.6M
- May 2023Series B$46.4M
- Mar 2023Grant (prize money)$11.8M
- Oct 2022Series A—
#4
Seed · Barcelona, Catalonia · founded 2021 · 9 employees$6.8Mraised▾
Developer of next generation of gene editing tools to cure diseases. The company has combined the CRISPR systems with the gene transfer efficiency of viral integrases and transposases. It helps in introducing DNA into the genome with sequence-specific DNA binding proteins for developing gene therapies.
- Sep 2025Seed$12.5M
- Jan 2023Grant (prize money)$540.6K
- Mar 2022Seed$1.7M
- Dec 2021Seed$5.1M
#5
Series A · Madrid, Community of Madrid · founded 2010 · 35 employees$6.9Mraised▾
Provider of diagnostic tools to support personalized cancer treatment. The company has developed prognostic, diagnostic, and predictive tests for lung cancer, colorectal cancer, and prostate cancer. Its colon cancer test ColoFast is a blood-based miRNA test for early detection of colon cancer. It is also developing DiagnoLung which is a blood-based ELISA test that measures the level of three protein biomarkers to screen high-risk patients for non-small-cell lung cancer.
- Feb 2025Venture Debt$15.6M
- Aug 2022Grant (prize money)$2.6M
- Jun 2021Grant (prize money)$3.4M
- Oct 2020Grant (prize money)$152.1K
#6
Series A · Barcelona, Catalonia · founded 2013 · 23 employees$11.2Mraised▾
Sequentia Biotech offers services and technologies in the field of bioinformatics. Work is organised into four specialised divisions: Sequentia Green, Sequentia Health, Sequentia Research, and Sequentia Training. The offerings include bioinformatics services, NGS services along with software for data analysis. It also has custom databses such as database for Plant resistance gene database PRGdb, Variation DB etc.
- Sep 2024Series A$11.2M
- Sep 2022Grant (prize money)$2.1M
- 2021Grant (prize money)$61.3K
- Apr 2021Grant (prize money)$86.6K
#7
Seed · San Sebastian, Basque Country · founded 2015 · 83 employees$3.9Mraised▾
Developer and manufacturer of lentiviral vectors. It offers manufacturing-related services such as analytical methods, stability studies, final products, cell banks, and regulatory support. It has developed Lentisoma which is a patented episomal non-integrative lentiviral vector.
- Dec 2024PE—
- Sep 2019Seed$3.9M
#8
Series A · Esplugues De Llobregat, Catalonia · founded 2015$984.7Kraised▾
Provider of a platform for personal genomic analysis. The company provides DNA sequencing services and computing services for genomic analysis. Users can obtain, analyze and manage their complete genomic sequence from the company's cloud platform.
- Dec 2024Series A$5.3M
- Oct 2022Seed$984.7K
- Jun 2018Grant (prize money)$58.2K
- Jan 2018Grant (prize money)$60.1K
#9
Series A · Barcelona, Catalonia · founded 2017 · 10 employees$12.9Mraised▾
Provider of diagnostic services for early detection of Alzheimer's disease. The company is developing diagnostic tests by using next-generation sequencing analysis for the detection of biomarkers β-amyloid nor tau. The test is based on an epigenetic analysis in blood samples, covering the analysis of a large number of methylcytosines in mtDNA.
- Oct 2023Series A$5.7M
- Jan 2021Grant (prize money)$3M
- Aug 2020Series A$5M
- Mar 2019Seed$2.3M
#10
Seed · Palma, Balearic Islands · founded 2019$1.1Mraised▾
Provider of saliva-based DNA testing kits for genetic studies. The platform enables the user to buy DNA testing kits for health, fitness, and nutrition analysis. User can order the kit, collect the saliva sample, send it to the laboratory, and receives the result through the email.
- Oct 2024Seed$1.1M
#11
Seed · Barcelona, Catalonia · founded 2015 · 20 employees$2.9Mraised▾
Genomics platform for acquiring, storing, and sharing personal genomic information. Genomcore provides end-customers a secure and compliant genomics platform for acquiring, storing, and sharing personal genomic information for its use in clinical and non-clinical applications. The company provides DNA sequencing services and computing services for genomic analysis. Users can obtain, analyze and manage their complete genomic sequence from the company's cloud platform.
- Feb 2024Seed—
- Jul 2020Seed$2.7M
- Jun 2015Seed$100K
- Feb 2015Seed$102K
#12
Series C · Barcelona, Catalonia · founded 2010$53.7Mraised▾
Provider of a diagnostic platform for molecular diagnostics and immunoassays. The proprietary DiagCore comprises an Analyzer that runs on consumable DiagCore cartridges. The STAT-Molecular cartridge automates sample homogenization, cell disruption, nucleic acid purification and delivers up to 50-plex target detection employing qPCR. This test cartridge is designed to automate molecular assays in the fields of infectious diseases, oncology, coagulation, prenatal, inherited diseases, or companion diagnostics. It offers test cartridges designed to automate immunoassays for critical care markers such as Procalcitonin (Sepsis), Troponin (AMI), Ngal (AKI), C-reactive protein (Inflammation), hCG (pregnancy), among others.
- Oct 2016Series C—
- Apr 2016Series C$28.5M
- May 2013Series B$22.3M
- 2011Series A$2.9M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Genomics coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.